Company Profile

Coridea Inc (AKA: Coridea LLC~Coridea NC1 Inc)
Profile last edited on: 5/21/2018      CAGE: 71NT6      UEI: L5D8PHYBNJH7

Business Identifier: Medical device technology incubator
Year Founded
2003
First Award
2015
Latest Award
2022
Program Status
Active
Popularity Index
Is this YOUR Company?
Ensure accuracy and completeness of YOUR Company Profile by completing the brief Survey Instrument attached
Do you know about this Awardees?
Let us encourage you to provide any data which would enhance the completeness of this firm's profile.

Location Information

315 West 36th Street 5th Floor
New York, NY 10018
   (212) 929-6600
   info@coridea.com
   www.coridea.com
Location: Single
Congr. District: 10
County: New York

Public Profile

CORIDEA is an idea generator, technology incubator and consulting firm that applies established technologies to new targets in the cardio-renal and cardio-pulmonary fields. Since its inception in 2003, Coridea has launched six startup companies including Ardian, CHF Solutions, and Respicardia (formerly, Cardiac Concepts). The $800 MM acquisition of Ardian by Medtronic marked the highest-priced venture capital-backed pre-revenue medical device acquisition to date. With 65 U.S. patents licensed by companies such as Evalve, Zoll Medical, Nephros, and PLC Medical; over $150 million in venture capital financing; and the invention of 2011 Edison Award-winning Symplicity® Catheter System™, Coridea is a leader in medical device innovation.

Extent of SBIR involvement

User Avatar

Synopsis: Awardee Business Condition

Employee Range
1-4
Revenue Range
Less than .5M
VC funded?
Yes
Public/Private
Privately Held
Stock Info
----
IP Holdings
10-14

Awards Distribution by Agency

Most Recent SBIR Projects

Year Phase Agency Total Amount
2023 1 NIH $907,248
Project Title: Minimally Invasive High Intensity Therapeutic Ultrasound for the Treatment of Obstructive Hypertrophic Cardiomyopathy
2022 1 NIH $278,784
Project Title: On Demand Electrostimulation
2022 2 NIH $2,166,021
Project Title: Endobronchial Supervalve for the Treatment of Emphysema
2022 2 NIH $1,792,841
Project Title: Novel Minimally Invasive Endobronchial Approach for Lung Cancer Ablation
2020 2 NIH $3,967,963
Project Title: Painless Defibrillation

Key People / Management

  Mark Gelfland -- Co Founder

  Mark Gelfand

  Howard D Levin -- Co Founder